Daniel D. Long
Svp, Drug Discovery at Septerna, Inc. (SEPN)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $951K
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Sep 3SEC | SEPNSepterna, Inc. | Sell Plan | 3,33396,412 held (−3%) | $37.83 | $126K | +1.4% |
| Aug 5SEC | SEPNSepterna, Inc. | Sell Plan | 1,00098,746 held (−1%) | $33.98 | $34K | +12.9% |
| Aug 5SEC | SEPNSepterna, Inc. | Sell Plan | 2,33496,412 held (−2%) | $34.68 | $81K | +10.6% |
| Jul 2SEC | SEPNSepterna, Inc. | Sell Plan | 2,10097,645 held (−2%) | $34.10 | $72K | +12.5% |
| Jul 2SEC | SEPNSepterna, Inc. | Sell Plan | 1,23396,412 held (−1%) | $34.81 | $43K | +10.2% |
| Jun 24SEC | SEPNSepterna, Inc. | Sell Plan | 8,000103,412 held (−7%) | $35.10 | $281K | +9.3% |
| Jun 24SEC | SEPNSepterna, Inc. | Sell Plan | 7,00096,412 held (−7%) | $35.97 | $252K | +6.7% |
| Nov 13SEC | SEPNSepterna, Inc. | Sell | 3,50192,911 held (−4%) | $18.06 | $63K | +112.5% |
- Sell
Svp, Drug Discovery Daniel D. Long sold $126K of SEPN at $37.83 — pre-scheduled 10b5-1 plan sale.
- Sell
Svp, Drug Discovery Daniel D. Long sold $34K of SEPN at $33.98 — pre-scheduled 10b5-1 plan sale.
- Sell
Svp, Drug Discovery Daniel D. Long sold $81K of SEPN at $34.68 — pre-scheduled 10b5-1 plan sale.
- Sell
Svp, Drug Discovery Daniel D. Long sold $72K of SEPN at $34.10 — pre-scheduled 10b5-1 plan sale.
- Sell
Svp, Drug Discovery Daniel D. Long sold $43K of SEPN at $34.81 — pre-scheduled 10b5-1 plan sale.
- Sell
Svp, Drug Discovery Daniel D. Long sold $281K of SEPN at $35.10 — pre-scheduled 10b5-1 plan sale.